<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270803</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-05-EE-03-124-CTIL</org_study_id>
    <nct_id>NCT00270803</nct_id>
  </id_info>
  <brief_title>The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana</brief_title>
  <official_title>The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effects of 17mg and 13mg Delta THC on orientation and motor&#xD;
      coordination and brain metabolic activity in regular users of marijuana. Subjects were tested&#xD;
      twice, after smoking cigarettes with marijuana and after smoking cigarettes without&#xD;
      marijuana.On both occasions they performed on a virtual reality maze task. They were&#xD;
      afterwards scanned in Positron Emission Tomography (PET) with Fluoro-deoxy-glucose (FDG).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigates the effects of 17mg and 13mg Delta THC on orientation and motor&#xD;
      coordination and brain metabolic activity in regular users of marijuana. Subjects were tested&#xD;
      twice, after smoking cigarettes with marijuana and after smoking cigarettes without&#xD;
      marijuana. On both occasions they performed on a virtual reality maze task. They were&#xD;
      afterwards scanned in Positron Emission Tomography (PET) with Fluoro-deoxy-glucose (FDG). 12&#xD;
      subjects were tested so far on both conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain metabolic activity (FDG)</measure>
    <time_frame>30-40 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reaction time (RTs) and errors in performance</measure>
    <time_frame>40 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective ratings on visual analog scale</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Marijuana Dependence</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Low nicotine cigarettes without THC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tetra Hydro Cannabinol (THC)</intervention_name>
    <description>Oral THC 13mg and 17mg smoked in low nicotine cigarettes</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Marijuana, cannabis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Marijuana dependence&#xD;
&#xD;
          -  Age 20-65&#xD;
&#xD;
          -  Male and female&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Dependence on other substances&#xD;
&#xD;
          -  Psychiatric diagnosis apart from marijuana dependence&#xD;
&#xD;
          -  Neurological disorder&#xD;
&#xD;
          -  Young persons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aviv M Weinstein, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Einat Even-Sapir, M.D. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sourasky Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Nuclear Medicine</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2005</verification_date>
  <study_first_submitted>December 25, 2005</study_first_submitted>
  <study_first_submitted_qc>December 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2005</study_first_posted>
  <last_update_submitted>May 6, 2008</last_update_submitted>
  <last_update_submitted_qc>May 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Michal Roll</name_title>
    <organization>Sourasky Medical Center Tel Aviv</organization>
  </responsible_party>
  <keyword>Marijuana, FDG, PET, maze, THC, motor coordination.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

